US Stock MarketDetailed Quotes

Heron Therapeutics (HRTX)

Watchlist

1.0000
+0.0600+6.38%

Close Apr 17 16:00 ET

1.0300
+0.0300+3.00%

Post 19:32 ET

188.54MMarket Cap-8.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Heron Therapeutics (HRTX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.47%-27.59M

22.04%-9.18M

-60.52%1.33M

-136.06%-10.87M

6.79%-8.87M

61.68%-22.53M

-579.84%-11.78M

136.73%3.37M

83.05%-4.6M

61.78%-9.52M

Net income from continuing operations

-48.71%-20.2M

-180.64%-2.95M

-260.87%-17.5M

74.22%-2.38M

183.39%2.64M

87.72%-13.58M

134.16%3.66M

80.61%-4.85M

78.04%-9.24M

90.36%-3.16M

Operating gains losses

168.21%11.75M

--414K

--11.24M

--129K

---34K

598.88%4.38M

----

Depreciation and amortization

-7.14%2.31M

-7.57%537K

5.85%615K

-4.68%611K

-20.03%551K

-14.04%2.49M

-18.74%581K

-20.08%581K

-13.26%641K

-4.04%689K

Other non cash items

-14.98%817K

-32.00%204K

-48.01%196K

43.06%206K

50.71%211K

183.48%961K

84.05%300K

416.44%377K

176.92%144K

174.51%140K

Change In working capital

-15.49%-31.88M

50.58%-9.07M

-14.43%3.64M

-250.41%-11.99M

-43.31%-14.46M

-264.40%-27.6M

-318.32%-18.34M

-50.13%4.25M

-986.53%-3.42M

-1,811.36%-10.09M

-Change in receivables

42.88%-10.71M

27.88%-8.54M

-116.73%-1.12M

85.75%-1.2M

102.80%145K

-131.75%-18.74M

-423.73%-11.84M

-48.29%6.67M

66.78%-8.39M

-962.73%-5.19M

-Change in inventory

-181.01%-31.05M

-96.77%-14.19M

195.27%2.94M

-4,000.51%-16.03M

-939.12%-3.77M

-188.66%-11.05M

-6,900.00%-7.21M

-217.97%-3.09M

-105.26%-391K

-114.44%-363K

-Change in prepaid assets

108.84%878K

188.15%5.43M

-36.81%-5.25M

3,118.69%9.3M

-3,775.68%-8.6M

-164.35%-9.93M

-226.06%-6.16M

-2,330.23%-3.84M

-96.95%289K

-124.50%-222K

-Change in payables and accrued expense

-25.73%9M

19.89%8.23M

56.73%7.06M

-180.24%-4.07M

48.36%-2.23M

502.46%12.12M

18,171.05%6.87M

162.98%4.51M

-41.98%5.07M

4.99%-4.32M

Cash from discontinued investing activities

Operating cash flow

-22.47%-27.59M

22.04%-9.18M

-60.52%1.33M

-136.06%-10.87M

6.79%-8.87M

61.68%-22.53M

-579.84%-11.78M

136.73%3.37M

83.05%-4.6M

61.78%-9.52M

Investing cash flow

Cash flow from continuing investing activities

-14.45%16.01M

-147.78%-5.46M

198.69%11.86M

258.11%7.33M

77.86%2.27M

4.00%18.71M

229.22%11.42M

117.10%3.97M

-84.51%2.05M

-96.53%1.28M

Net PPE purchase and sale

86.96%-219K

102.62%16K

106.73%29K

69.07%-197K

---67K

-9.60%-1.68M

-157.81%-611K

45.65%-431K

-129.14%-637K

--0

Net investment purchase and sale

-20.42%16.23M

-145.49%-5.47M

168.78%11.83M

180.48%7.53M

83.10%2.34M

4.43%20.39M

239.89%12.03M

119.62%4.4M

-80.11%2.69M

-96.55%1.28M

Cash from discontinued investing activities

Investing cash flow

-14.45%16.01M

-147.78%-5.46M

198.69%11.86M

258.11%7.33M

77.86%2.27M

4.00%18.71M

229.22%11.42M

117.10%3.97M

-84.51%2.05M

-96.53%1.28M

Financing cash flow

Cash flow from continuing financing activities

1,434.79%14.43M

-48.23%219K

95,350.00%13.36M

-98.26%940K

112.56%423K

-99.97%14K

54.23%492K

105.29%11K

Net issuance payments of debt

---12.76M

---4.79M

----

--0

----

Net common stock issuance

--18.31M

---1.53M

----

--0

----

Net preferred stock issuance

--7.86M

--0

----

--0

----

Proceeds from stock option exercised by employees

7.77%1.01M

-48.23%219K

-464.29%-51K

----

46,900.00%940K

112.56%423K

104.55%14K

54.23%492K

105.29%11K

Cash from discontinued financing activities

Financing cash flow

1,434.79%14.43M

-48.23%219K

95,350.00%13.36M

58.74%781K

481.82%64K

-98.26%940K

112.56%423K

-99.97%14K

54.23%492K

105.29%11K

Net cash flow

Beginning cash position

-10.03%25.8M

67.31%43.07M

-10.17%16.52M

-5.78%19.27M

-10.03%25.8M

86.65%28.68M

-26.16%25.74M

36.58%18.39M

-24.51%20.45M

86.65%28.68M

Current changes in cash

198.96%2.85M

-23,740.98%-14.42M

261.01%26.55M

-33.38%-2.75M

20.59%-6.53M

-121.60%-2.88M

100.99%61K

-65.63%7.36M

84.85%-2.06M

-170.16%-8.23M

End cash Position

11.03%28.65M

67.31%43.07M

-10.17%16.52M

-5.78%19.27M

-10.03%25.8M

-26.16%25.74M

36.58%18.39M

-24.51%20.45M

Free cash flow

-15.16%-27.91M

26.04%-9.18M

-54.73%1.33M

-111.33%-11.08M

5.64%-8.98M

59.83%-24.24M

-663.17%-12.42M

129.48%2.94M

80.90%-5.24M

62.12%-9.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.47%-27.59M	22.04%-9.18M	-60.52%1.33M	-136.06%-10.87M	6.79%-8.87M	61.68%-22.53M	-579.84%-11.78M	136.73%3.37M	83.05%-4.6M	61.78%-9.52M
Net income from continuing operations	-48.71%-20.2M	-180.64%-2.95M	-260.87%-17.5M	74.22%-2.38M	183.39%2.64M	87.72%-13.58M	134.16%3.66M	80.61%-4.85M	78.04%-9.24M	90.36%-3.16M
Operating gains losses	168.21%11.75M	--414K	--11.24M	--129K	---34K	598.88%4.38M	----	----	----	----
Depreciation and amortization	-7.14%2.31M	-7.57%537K	5.85%615K	-4.68%611K	-20.03%551K	-14.04%2.49M	-18.74%581K	-20.08%581K	-13.26%641K	-4.04%689K
Other non cash items	-14.98%817K	-32.00%204K	-48.01%196K	43.06%206K	50.71%211K	183.48%961K	84.05%300K	416.44%377K	176.92%144K	174.51%140K
Change In working capital	-15.49%-31.88M	50.58%-9.07M	-14.43%3.64M	-250.41%-11.99M	-43.31%-14.46M	-264.40%-27.6M	-318.32%-18.34M	-50.13%4.25M	-986.53%-3.42M	-1,811.36%-10.09M
-Change in receivables	42.88%-10.71M	27.88%-8.54M	-116.73%-1.12M	85.75%-1.2M	102.80%145K	-131.75%-18.74M	-423.73%-11.84M	-48.29%6.67M	66.78%-8.39M	-962.73%-5.19M
-Change in inventory	-181.01%-31.05M	-96.77%-14.19M	195.27%2.94M	-4,000.51%-16.03M	-939.12%-3.77M	-188.66%-11.05M	-6,900.00%-7.21M	-217.97%-3.09M	-105.26%-391K	-114.44%-363K
-Change in prepaid assets	108.84%878K	188.15%5.43M	-36.81%-5.25M	3,118.69%9.3M	-3,775.68%-8.6M	-164.35%-9.93M	-226.06%-6.16M	-2,330.23%-3.84M	-96.95%289K	-124.50%-222K
-Change in payables and accrued expense	-25.73%9M	19.89%8.23M	56.73%7.06M	-180.24%-4.07M	48.36%-2.23M	502.46%12.12M	18,171.05%6.87M	162.98%4.51M	-41.98%5.07M	4.99%-4.32M
Cash from discontinued investing activities
Operating cash flow	-22.47%-27.59M	22.04%-9.18M	-60.52%1.33M	-136.06%-10.87M	6.79%-8.87M	61.68%-22.53M	-579.84%-11.78M	136.73%3.37M	83.05%-4.6M	61.78%-9.52M
Investing cash flow
Cash flow from continuing investing activities	-14.45%16.01M	-147.78%-5.46M	198.69%11.86M	258.11%7.33M	77.86%2.27M	4.00%18.71M	229.22%11.42M	117.10%3.97M	-84.51%2.05M	-96.53%1.28M
Net PPE purchase and sale	86.96%-219K	102.62%16K	106.73%29K	69.07%-197K	---67K	-9.60%-1.68M	-157.81%-611K	45.65%-431K	-129.14%-637K	--0
Net investment purchase and sale	-20.42%16.23M	-145.49%-5.47M	168.78%11.83M	180.48%7.53M	83.10%2.34M	4.43%20.39M	239.89%12.03M	119.62%4.4M	-80.11%2.69M	-96.55%1.28M
Cash from discontinued investing activities
Investing cash flow	-14.45%16.01M	-147.78%-5.46M	198.69%11.86M	258.11%7.33M	77.86%2.27M	4.00%18.71M	229.22%11.42M	117.10%3.97M	-84.51%2.05M	-96.53%1.28M
Financing cash flow
Cash flow from continuing financing activities	1,434.79%14.43M	-48.23%219K	95,350.00%13.36M			-98.26%940K	112.56%423K	-99.97%14K	54.23%492K	105.29%11K
Net issuance payments of debt	---12.76M	---4.79M	----	----	----	--0	--0	----	----	----
Net common stock issuance	--18.31M	---1.53M	----	----	----	--0	--0	----	----	----
Net preferred stock issuance	--7.86M	--0	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	7.77%1.01M	-48.23%219K	-464.29%-51K	----	----	46,900.00%940K	112.56%423K	104.55%14K	54.23%492K	105.29%11K
Cash from discontinued financing activities
Financing cash flow	1,434.79%14.43M	-48.23%219K	95,350.00%13.36M	58.74%781K	481.82%64K	-98.26%940K	112.56%423K	-99.97%14K	54.23%492K	105.29%11K
Net cash flow
Beginning cash position	-10.03%25.8M	67.31%43.07M	-10.17%16.52M	-5.78%19.27M	-10.03%25.8M	86.65%28.68M	-26.16%25.74M	36.58%18.39M	-24.51%20.45M	86.65%28.68M
Current changes in cash	198.96%2.85M	-23,740.98%-14.42M	261.01%26.55M	-33.38%-2.75M	20.59%-6.53M	-121.60%-2.88M	100.99%61K	-65.63%7.36M	84.85%-2.06M	-170.16%-8.23M
End cash Position	11.03%28.65M	11.03%28.65M	67.31%43.07M	-10.17%16.52M	-5.78%19.27M	-10.03%25.8M	-10.03%25.8M	-26.16%25.74M	36.58%18.39M	-24.51%20.45M
Free cash flow	-15.16%-27.91M	26.04%-9.18M	-54.73%1.33M	-111.33%-11.08M	5.64%-8.98M	59.83%-24.24M	-663.17%-12.42M	129.48%2.94M	80.90%-5.24M	62.12%-9.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm